# Bloodworks – FDA Inspection, Nov 2, 2017

Source: https://www.keypedia.com/records/fda_inspections/bloodworks/28b8eca4-785d-4248-8587-48b8d7d2bd53
Source feed: FDA_Inspections

> FDA inspection 1031409 of Bloodworks, November 02, 2017. Classification: No Action Indicated (NAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1031409
- Company Name: Bloodworks
- Inspection Date: 2017-11-02
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1312856 - 2026-04-15
- FDA Inspection 1167416 - 2022-03-15
- [FDA Inspection 904964 - 2014-11-28](https://www.keypedia.com/records/fda_inspections/bloodworks/6767c5ba-9e35-45f9-9402-fc5be7166f6a)
- FDA Inspection 812004 - 2012-12-13
- [FDA Inspection 749837 - 2011-10-14](https://www.keypedia.com/records/fda_inspections/bloodworks/0b73bc67-6322-4745-8934-4c7ed0ce0a8d)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/peter-s-kessler/f3a9dea7-3a2d-4c86-9ec6-97791f9b6c21)

Company: https://www.keypedia.com/companies/bloodworks/30ba73e7-0146-4206-9f44-095b277a6eef

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d